| scholarly article | Q13442814 |
| P2093 | author name string | Belinda Willard | |
| Venkaiah Betapudi | |||
| Keith R McCrae | |||
| Meifang Wu | |||
| George Lominadze | |||
| Linda Hsi | |||
| P2860 | cites work | High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II | Q22254095 |
| Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 | ||
| Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies | Q28203584 | ||
| Proteomic analysis of human neutrophil granules | Q28258795 | ||
| Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab | Q28260452 | ||
| Non-muscle myosin II takes centre stage in cell adhesion and migration | Q28262326 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146. | Q30164911 | ||
| Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner | Q30304130 | ||
| A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies | Q30422807 | ||
| Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility | Q30471919 | ||
| Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. | Q30497721 | ||
| Activation of cultured vascular endothelial cells by antiphospholipid antibodies. | Q33488617 | ||
| Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease. | Q35004519 | ||
| Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors | Q35067429 | ||
| Endothelial microparticles as markers of endothelial dysfunction | Q35672659 | ||
| Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay | Q35792021 | ||
| Current concepts on the pathogenesis of the antiphospholipid syndrome | Q36598158 | ||
| Microparticles as mediators of cellular cross-talk in inflammatory disease | Q36687910 | ||
| Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients | Q36947164 | ||
| Nonmuscle myosin II is responsible for maintaining endothelial cell basal tone and stress fiber integrity | Q36955846 | ||
| Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms | Q37249524 | ||
| Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome? | Q37510353 | ||
| The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome | Q37721602 | ||
| Microparticles in physiological and in pathological conditions | Q37799778 | ||
| Cellular mechanisms underlying the formation of circulating microparticles | Q37821168 | ||
| Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis | Q37922118 | ||
| Recent developments in our understanding of the antiphospholipid syndrome | Q37991066 | ||
| The significance of autoantibodies against β2-glycoprotein I. | Q38007155 | ||
| Cooperation between β- and γ-cytoplasmic actins in the mechanical regulation of endothelial microparticle formation. | Q39243315 | ||
| Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. | Q40276225 | ||
| Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration | Q40285029 | ||
| Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms | Q40344286 | ||
| In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. | Q40851071 | ||
| Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies | Q48032183 | ||
| Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts | Q56991404 | ||
| Annexin A2 mediates endothelial cell activation by antiphospholipid/anti- 2 glycoprotein I antibodies | Q57374964 | ||
| Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti-β2-Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β2-Glycoprotein I and Induce Endothelial Activation | Q62395215 | ||
| Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
| Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis | Q70529807 | ||
| Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules | Q71707854 | ||
| Antiphospholipid antibodies activate vascular endothelial cells | Q71747732 | ||
| Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin | Q73396795 | ||
| Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome | Q79826484 | ||
| Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation | Q80851651 | ||
| Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK- | Q82132738 | ||
| Antiphospholipid antibodies and the protein C pathway | Q83954291 | ||
| The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study | Q84438431 | ||
| MP's and VTE's: Fact or fiction | Q84980460 | ||
| Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndrome | Q85437025 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| endothelium | Q111140 | ||
| P304 | page(s) | 3808-3817 | |
| P577 | publication date | 2013-08-16 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway | |
| P478 | volume | 122 |
| Q89509404 | A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells |
| Q36928587 | A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesicles |
| Q41873189 | Bad (or good) things come in small packages. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q54996884 | Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome. |
| Q34684028 | Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome |
| Q47982275 | Diagnosis and management of the antiphospholipid syndrome |
| Q91715341 | Insight into the Role of Extracellular Vesicles in Lysosomal Storage Disorders |
| Q54277572 | NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signalling pathways in the endothelium. |
| Q57177487 | The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases |
| Q51064693 | Vitamin D suppresses oxidative stress-induced microparticle release by human umbilical vein endothelial cells. |
Search more.